Mitsubishi UFJ Asset Management (UK) Ltd.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1694895
LONDON, X0
Position in VRTX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$993,460
-$792,700 QoQ
Shares Held
2,000
-50.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#220
of 593 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Asset Management (UK) Ltd. holds $4,092,972 across 7 Biotechnology names. VRTX ranks #1 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,000 | $993,460 | |
| 2 | IMNM |
Immunome Inc.
|
45,000 | $953,550 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
|
5,500 | $840,510 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
2,900 | $543,112 | |
| 5 | BHVN |
Biohaven Ltd.
|
30,000 | $446,400 | |
| 6 | HELP |
Cybin Inc.
|
31,000 | $204,910 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,000 | $111,030 |
All Filings in VRTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $993,460 | 2,000 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $1,786,160 | 4,000 | Shares | Defined | 2026-05-08 | |
| 2025-09-30 | $861,608 | 2,200 | Shares | Defined | 2025-11-10 | |
| 2025-03-31 | $484,820 | 1,000 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,006,750 | 2,500 | Shares | Defined | 2025-01-17 | |
| No filing history on record for this holder in this stock. | ||||||